GeneMatrix Market Cap

GeneMatrix has a market cap or net worth of 45.27 billion as of March 9, 2026. Its market cap has decreased by -15.91% in one year.

Market Cap

45.27B

Enterprise Value

n/a

Revenue

4.72B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,220.00

Market Cap Chart

Since November 6, 2009, GeneMatrix's market cap has increased from 33.85B to 45.27B, an increase of 33.75%. That is a compound annual growth rate of 1.80%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	45.27B	-9.57%
Dec 30, 2025	50.07B	-9.74%
Dec 30, 2024	55.47B	-12.40%
Dec 28, 2023	63.32B	-23.43%
Dec 29, 2022	82.69B	-58.54%
Dec 30, 2021	199.45B	-62.10%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Seoulin Bioscience	56.23B
Protia	63.87B
Green Cross Medical Science	79.03B
HLB Panagene	92.99B
Cytogen	107.04B
Median Diagnostics	17.12B
PeopleBio	16.00B
GENINUS	140.91B

Market Cap Rankings